Ewes from the Booroola strain of Australian Mé rino sheep are characterized by high ovulation rate and litter size. This phenotype is due to the action of the FecB B allele of a major gene named FecB, as determined by statistical analysis of phenotypic data. By genetic analysis of 31 informative half-sib families from heterozygous sires, we showed that the FecB locus is situated in the region of ovine chromosome 6 corresponding to the human chromosome 4q22-23 that contains the bone morphogenetic protein receptor IB (BMPR-IB) gene encoding a member of the transforming growth factor-␤ (TGF-␤) receptor family. A nonconservative substitution (Q249R) in the BMPR-IB coding sequence was found to be associated fully with the hyperprolificacy phenotype of Booroola ewes. In vitro, ovarian granulosa cells from FecB B ͞FecB B ewes were less responsive than granulosa cells from FecB ؉ ͞FecB ؉ ewes to the inhibitory effect on steroidogenesis of GDF-5 and BMP-4, natural ligands of BMPR-IB. It is suggested that in FecB B ͞FecB B ewes, BMPR-IB would be inactivated partially, leading to an advanced differentiation of granulosa cells and an advanced maturation of ovulatory follicles.
Booroola mutation can be segregated on the basis of ovulation rate recordings of five or more, three or four, and one or two, respectively (1, 2) . Extensive physiological analysis has established that the product of the FecB gene influences both pituitary and ovarian activity. Particularly in ovarian follicles, this gene product acts directly or indirectly by inducing a precocious maturation of ovarian follicles, which ovulate at a smaller size (3) . The identity of the FecB gene and the physiological mechanisms leading to the differences in ovulation rate remain unknown (4) .
With the aim to identify the FecB gene, we established a detailed genetic map of the ovine FecB region. On sheep chromosome 6, the FecB gene is located between the SPP1 and EGF genes (5, 6) . As extensive homology has been demonstrated with the orthologous 4q21-25 region of human chromosome 4 (7), we developed a comparative mapping strategy that converged on a chromosomal region containing the bone morphogenetic protein receptor IB (BMPR-IB) gene. In this paper we show that a mutation in the coding sequence of the BMPR-IB gene was found to be associated fully with the FecB B Data deposition: The sequence reported in this paper has been deposited in the GenBank database (accession no. AF298885). † To whom reprint requests should be addressed. E-mail: mulsant@toulouse.inra.fr.
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standard procedures by using markers described in Table 1 . Microsatellite 300U was analyzed by autoradiography of primerlabeled PCR fragments. Microsatellite LSCV043 was analyzed on Metaphor gels. All markers were sequenced. Genetic segregation analysis was done with the CRIMAP software (12) using the ''build'' and ''flips'' options. The FecB genotype of 12 progeny individuals was inconsistent with their genotype at all marker loci. These animals were considered to correspond to misclassification cases and were excluded from the analysis.
BMPR-IB Analysis. Extraction of mRNA from granulosa cells was realized as described by Chomczynski and Sacchi (13) . cDNA synthesis was achieved by RT Superscript II from GIBCO͞BRL with a (dT) [15] [16] [17] [18] primer. Coding sequences were amplified with primer pairs B3 and B4 (Table 1 ). Sequences were controlled with different internal primers. Determination of BMPR-IB intron-exon junctions was carried out by sequencing subclones of BACs 118b4 and 382c4 with internal BMPR-IB primers. The Q249R mutation was tested by single-strand conformation analysis using primers flanking the A 3 G transition (OB2 in Table  1 ). Reverse transcription (RT)-PCR was performed by using primers 5Ј-CGAATGAAGTTGACATACCAC-3Ј and 5Ј-TCGTAAGAGGGGTCACTGG-3Ј located in two different exons at positions 1,129 and 1,342 to discriminate eventual amplification from genomic DNA contaminants. We also designed primers 5Ј-CTGACCTGCCGCCTGGAGAAA-3Ј and 5Ј-GTAGAAGAGTGAGTGTCGCTGTT-3Ј to assess the expression of ovine G3PDH mRNA (GenBank accession no. U39091), used as an internal control of reverse transcription RT-PCR. Multiple sequence alignments were performed by using MULTALIN software (14) .
Granulosa Cell Cultures. Granulosa cells were recovered from antral follicles of 1-3 mm in diameter as described (15) . Granulosa cells were seeded at 100,000 viable cells per well in 96-well plates and cultured for 96 h at 37°C with 5% CO 2 in serum-free McCoy's 5a medium (Sigma) containing insulin (100 ng͞ml, Sigma) and insulin-like growth factor-1 (10 ng͞ml, CIBA-Geigy) according to a previously described method (16) . Cultures were performed with or without follicle-stimulating hormone (FSH, 5 ng͞ml, purified ovine FSH-20, lot n°AFP-7028D, National Hormone Pituitary Program, National Institute of Diabetes and Digestive and Kidney Diseases) and in the presence of various concentrations (0, 1, 5, 10, and 50 ng͞ml) of dimeric recombinant human GDF-5 (Biopharm, Heidelberg, Germany), recombinant human BMP-4 (Genetics Institute, Cambridge, MA), or 50 ng͞ml of monomeric recombinant human GDF-5 (Biopharm) as negative control. Each combination of treatments was tested in triplicate for each culture and in three independent cultures. In four independent cultures, proliferation was assessed by studying [ Progesterone RIA. Progesterone concentrations in the culture media were measured in a direct RIA as described (18) . The limit detection of the assay was 12 pg per tube, and the intra-assay coefficient of variation was 10%.
Molecular Modeling. Modeling of BMPR-IB was performed with the SWISSMODEL application (http:͞͞www.expasy.ch͞swissmod͞ SWISS-MODEL.html) by using the human T␤R-I͞FKBP12 complex as template (Protein Data Bank identifier 1B6CB). Structure visualization was performed by using the INSIGHT II program package (Molecular Simulations, Waltham, MA).
Data Analysis. All experimental data are presented as mean Ϯ SEM. For results of progesterone secretion, data were expressed as percentages of the amount of progesterone secreted by cells cultured in the absence of GDF-5 or BMP-4. For each genotype and culture condition (with or without FSH), the effects of ligands was studied by two-way ANOVA to appreciate the action of each dose of ligand as well as the variation between independent cultures. For each dose of ligand, the effect of genotype was studied by one-way ANOVA. All differences with P Ͼ 0.05 were considered nonsignificant.
Results
Genetic Analysis of the FecB Region. Five ruminant large insert (BAC or YAC) libraries were screened with (i) microsatellites of bovine chromosome 6 and (ii) comparative anchored tagged sequences corresponding to genes located on human chromosome 4q21-24, between the prepromultimerin and microsomal triglyceride transfer protein genes. Genetic markers were developed by partial sequencing of the isolated BACs or YACs, either in the form of microsatellites or single nucleotide polymorphisms (Table 1) . Linkage between markers including FecB was tested on a backcross experimental population of 31 half-sib families from heterozygous FecB B ͞FecB ϩ sires (400 informative meiosis for FecB). FecB was found to be situated between ETL1 (Ͻ1 centimorgan) and the microsatellite Bulge5, isolated from a bovine YAC screened with PDHA2-specific primers (Fig. 1) . The interval between ETL1 (position 477 centirays) and PDHA2 (483.7 centirays) on the GB4 human irradiation map (http:͞͞ www.ncbi.nlm.nih.gov͞genemap͞) contains two identified genes at position 480 centirays: BMPR-IB and UNC5C. Both genes were found in the same sheep BAC clones, 118b4 and 382c4. Two markers in the ends of the adjacent BACs, 471c6 and 300f2, defined critical recombination events on both sides of FecB. No recombination was observed between FecB and any marker from the 382c4 BAC clone (Fig. 1) .
BMPR-IB Sequence Analysis. The BMP system has been shown recently to be expressed in rat ovaries and to affect steroid synthesis of granulosa cells (19) . The BMPR-IB gene thus was considered as a positional candidate for FecB and studied in more detail. To determine the cDNA sequence of ovine BMPR-IB, primer pairs based on the human and mouse sequences were used to amplify a coding sequence of 1,509 bp from both FecB ϩ ͞FecB ϩ and FecB B ͞FecB B granulosa cells, as well as 47 and 211 bp of 5Ј and 3Ј untranslated sequences, respectively. The nucleotide sequence of the wild-type allele showed 93% identity with the human BMPR-IB coding sequence. The predicted protein sequence (Fig. 2a) showed 98% identity with human BMPR-IB over a 502-aa overlap. The ovine coding sequence was contained in the overlap region between BACs 118b4 and 382c4 and was found to be divided into 10 exons. BLAST comparison of ovine BAC 118b4 sequences with the orthologous human BAC 115M7 (GenBank accession no. AC009920) showed a total conservation of the exons-introns organization of the gene between sheep and human.
The nucleotide sequence obtained from the FecB B allele was identical to the wild-type allele, except for a A 3 G transition at position 746, substituting the glutamine present in the wildtype sequence as well as in human and mouse sequences, with an arginine (CAG 3 CGG, Q249R, Fig. 2b ). Three additional polymorphisms were observed in wild-type sequences: a conservative substitution at position 1,113 of the coding sequence and two substitutions in the 3Ј untranslated region. The backcross population and 120 additional animals from 12 different breeds were genotyped by single-strand conformation analysis by using primers flanking the A 3 G transition. Only two alleles were obtained, which were found to be in total linkage disequilibrium with FecB. Indeed, the 249R allele was found in all FecB B carrier animals but in no control animal from Mérinos d'Arles (n ϭ 190) or other breeds (n ϭ 120), whereas allele sharing was observed for all the other markers from the nonrecombinant region. This is consistent with the full association of the 249R mutation in BMPR-IB with the Booroola phenotype. cells (P Ͻ 0.001), confirming that the presence of the FecB B mutation is associated with a decrease in proliferative activity of granulosa cells in small antral follicles (17, 22) . No effect of GDF-5 was observed on labeling index, but a slight increase was detected in the presence of BMP-4 (50 ng͞ml) for FecB ϩ ͞FecB As previously reported for small antral follicles (17), progesterone secretion by granulosa cells slightly increased in both (Fig. 4) . More likely, these results suggest a difference of functionality of the BMPR-IB receptor between FecB ϩ ͞ FecB ϩ and FecB B ͞FecB B granulosa cells.
Effect of BMPR-IB Ligands on Ovarian Granulosa Cells in

Molecular Modeling of the BMPR-IB Mutation.
Recently, the crystal structure of human type I transforming growth factor (TGF)-␤ receptor (T␤R-I) in complex with FKBP12, known as a negative modulator of T␤R-I family member activity, has been solved (23) . Modeling of ovine BMPR-IB using the T␤R-I͞FKBP12 complex as template indicated a very similar structure with no insertion or deletion supported by a high level of sequence identity (68%). The Q249 residue in ovine BMPR-IB lies critically between the GS domain and the L45 loop (Fig. 2a) . In the human T␤R-I structure, Q250, which corresponds to the BMPR-IB Q249, is located at the C terminus of the ␣C helix that makes contacts with the FKBP12 molecule (Fig. 5A ). Q250 does not form any obvious bond with the GS region nor with FKBP12 (Fig. 5B) . In contrast, the Q250R mutation is predicted to form a strong hydrogen bond with the main-chain oxygen of FKBP12 P88 (Fig. 5C, dashed line) . This interaction between FKBP12 and the receptor should be reinforced by a nearly parallel stacking interaction between electrons of R250 and FKBP12 H87 (Fig. 5C, arrow) . The same prediction can be made for the ovine BMPR-IB model that has been fitted on the T␤R-I͞ FKBP12 complex. Thus, the Q249R mutation may enhance the interaction between FKBP12 and BMPR-IB considerably, leading to a stronger inhibition of receptor activity.
Discussion
We have identified a mutation (Q249R) in the coding sequence of the BMPR-IB gene, which seems fully associated with the active site in which helix ␣GS2 is embedded) and the ␣GS1͞␣GS2 loop (GS region), which undergoes phosphorylation after kinase activation. The movement of ␣C helix, allowed by the GS region phosphorylation and͞or FKBP12 dissociation, is likely to be responsible partly for kinase activation (23) . Q250 does not form any obvious bond with the GS region nor with FKBP12 (Q198 O1 atom, the nearest neighbor, is 3.5 Å distant from Q250 N2 atom). (C) Consequence of the Q250R mutation. In the most probable conformer, R250 is predicted to form a strong hydrogen bond through its N1 atom with the main chain oxygen of FKBP12 P88 (dashed line). This interaction between FKBP12 and the receptor should be reinforced by a nearly parallel stacking interaction between electrons of R250 and FKBP12 H87 (e.g., 3.2 Å between R250 N and FKBP12 H87 N2; see arrow). The same prediction can be made for the ovine BMPR-IB model that has been fitted on the T␤R-I͞FKBP12 complex.
compared with noncarriers when isolated from the same follicle size class (17, (27) (28) (29) (30) . However, in preliminary studies with sheep granulosa cells, similar inhibitory effects of GDF-5 or BMP-4 have been observed on progesterone secretion of fully differentiated cells isolated from preovulatory follicles compared with less mature cells isolated from small antral follicles. Moreover, activin A, another member of the TGF-␤ family, also inhibited progesterone secretion, but unlike GDF-5 or BMP-4, it acted with the same efficiency on FecB B ͞FecB B and FecB ϩ ͞FecB ϩ granulosa cells from 1-to 3-mm diameter follicles (S.F., C.P., D.M., and P. Mouget, unpublished data). Thus it is suggested strongly that the BMP pathway is altered specifically in FecB B ͞ FecB B ovaries. Altogether, these results reinforce the hypothesis that the presence of the Q249R mutation in the BMPRI-B receptor is responsible for an alteration of its activity. This mutation likely leads to a partial rather than a complete inactivation of BMPR-IB. Indeed, in the mouse, targeted invalidation of the BMPR-IB gene causes clear skeletal defects (31) , whereas no defect in skeletal development of FecB B -carrier sheep has been reported yet. The Q249R mutation is not situated in a region previously shown to be involved in signal transduction (23) . However, modelization of the BMPR-IB three-dimensional structure indicates that the Q249R substitution likely reinforces the interaction of BMPR-IB with the immunophilin FKBP12, a negative modulator of type I TGF-␤ receptor family activity (32, 33) . One could hypothesize that the mutation would lead to a stronger inhibition of BMPR-IB activity by FKBP12, resulting in a decrease in cell responsiveness to specific ligands. Nevertheless, the role of FKBP12 in BMPR-IB action is unknown presently. As proposed for T␤R1 (34), FKBP12 both might prevent spontaneous transphosphorylation of type I BMP receptors by BMPR-II in the absence of ligand and modulate receptor activity in the presence of ligand.
Overall, we have shown that the Q249R mutation in BMPR-IB is associated fully with the hyperprolific phenotype of Booroola Mérino ewes. In FecB B carrier ewes, Q249R substitution would impair the inhibitory effect of BMPR-IB on granulosa cell steroidogenesis, leading to their advanced differentiation and an advanced maturation of follicles. Interestingly, very recent findings have shown correlations between hyperprolific phenotypes in Inverdale and Hanna ewes, and mutations in BMP-15, another member of the TGF-␤ family, which has been shown to be expressed specifically by oocytes (35) . However, in a Xenopus laevis mesoderm induction assay, BMP-4 but not BMP-15 was shown to induce ventral mesoderm, suggesting that BMP-15 is not a physiological ligand of BMPR-IB (36) . Nevertheless, all these results underline the crucial role of BMP family members and their receptors in the regulation of terminal folliculogenesis and the control of ovulation rate.
